Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Cross-reactivity evaluation of the RT-LAMP assay.

XH Xuejiao Hu
QD Qianyun Deng
JL Junmin Li
JC Jierong Chen
ZW Zixia Wang
XZ Xiqin Zhang
ZF Zhixin Fang
HL Haijian Li
YZ Yunhu Zhao
PY Pan Yu
WL Wenmin Li
XW Xiaoming Wang
SL Shan Li
LZ Lei Zhang
TH Tieying Hou
request Request a Protocol
ask Ask a question
Favorite

Synthesized plasmids of 12 common viral pathogens, including SARS, MERS, influenza A H1N1/H3N2, influenza B, human parainfluenza viruses (HPIV-1/2/3), respiratory syncytial virus (RSV-A/B), Epstein-Barr virus, human cytomegalovirus, human mastadenovirus (HAdV-B/E), enterovirus (EB-U/71), human rhinovirus (HRV-2/14/16), and coxsackievirus (CA16), were used to test potential cross-reactivity in the developed RT-LAMP assay. The RT-LAMP products obtained using these plasmid templates were assayed by 3% agarose gel electrophoresis.

Copyright and License information:  ©2020 Hu et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A